Home > Insider Trading > Filing (0001209191-10-024398)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267602	Alimera Sciences Inc	ALIM	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1366571	P L Vii Partners Intersouth	C/O Intersouth Partners 406 Blackwell Street, Suite 200 Durham NC 27701-3984	No	No	Yes	Yes
1416279	Dennis Dougherty	C/O Intersouth Partners 406 Blackwell Street, Suite 200 Durham NC 27701-3984	No	No	Yes	Yes
1416281	Mitch Mumma	C/O Intersouth Partners 406 Blackwell Street, Suite 200 Durham NC 27701-3984	No	No	Yes	Yes
1489732	Intersouth Associates Vii, Llc	C/O Intersouth Partners 406 Blackwell Street, Suite 200 Durham NC 27701-3984	No	No	Yes	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-27	576,859	$0.00	576,859	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2010-04-27	371,697	$0.00	948,556	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2010-04-27	196,210	$11.00	1,144,766	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Preferred Stock	Disposition	2010-04-27	576,859	$0.00	576,859	$0.00
Common Stock	Series C-1 Preferred Stock	Disposition	2010-04-27	371,697	$0.00	371,697	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Each outstanding share of preferred stock automatically converted into 1 share of common stock, immediately prior to the closing of the Issuer's initial public offering, for no additional consideration.
The reportable securities are owned directly by Intersouth Partners VII, L.P. ("IP VII"). Intersouth Associates VII, LLC ("IA VII, LLC") is the general partner of IP VII. IA VII, LLC disclaims beneficial ownership of these securities and this report shall not be deemed an admission that IA VII, LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. Each of Mitch Mumma ("Mumma") and Dennis Dougherty ("Dougherty") are the member managers of IA VII, LLC. Each of Mumma and Dougherty disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein.
Reflects a 3.4-for-1 reverse stock split, effective as of immediately prior to the effectiveness of the Registration Statement on Form S-1 (File No. 333-162782).
Immediately.
Not applicable.